CD163 and ovarian carcinoma: In this population-based analysis, we discovered a series of cancer progression-promoting changes (i.e., elevated levels of CD163, VEGF and COX-2 expression) in the TAMs that contacted the MUC2++/+++ ovarian cancer tissue and a number of complex and distinctive interactions between the cancer cells and the defending macrophages were identified.